Michael R. Bristow - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Medicine and Surgery, Molecular Biology

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, Altman NL, Lowes BD, Gilbert EM, Buttrick PM, Kao DP, Bristow MR. Correction: Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance. Plos One. 14: e0224389. PMID 31639152 DOI: 10.1371/journal.pone.0224389  0.68
2019 Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, Altman NL, Lowes BD, Gilbert EM, Buttrick PM, Kao DP, Bristow MR. Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance. Plos One. 14: e0221519. PMID 31469842 DOI: 10.1371/journal.pone.0221519  0.68
2019 Shamoun F, De Marco T, DeMets D, Mei C, Lindenfeld J, Saxon LA, Boehmer JP, Leigh J, Yong P, Feldman AM, Bristow MR. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy. Jacc. Heart Failure. PMID 30738980 DOI: 10.1016/j.jchf.2018.11.004  0.48
2018 O'Connor CM, Psotka MA, Fiuzat M, Lindenfeld J, Abraham WT, Bristow MR, Canos D, Harrington RA, Hillebrenner M, Jessup M, Malik FI, Solomon SD, Stockbridge N, Tcheng JE, Unger EF, et al. Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory. Journal of the American College of Cardiology. 71: 443-453. PMID 29389362 DOI: 10.1016/j.jacc.2017.11.048  0.48
2017 Bristow MR, Kao DP, Breathett KK, Altman NL, Gorcsan J, Gill EA, Lowes BD, Gilbert EM, Quaife RA, Mann DL. Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete? Jacc. Heart Failure. 5: 772-781. PMID 29096787 DOI: 10.1016/j.jchf.2017.09.009  0.68
2017 Sucharov CC, Kao DP, Port JD, Karimpour-Fard A, Quaife RA, Minobe W, Nunley K, Lowes BD, Gilbert EM, Bristow MR. Myocardial microRNAs associated with reverse remodeling in human heart failure. Jci Insight. 2: e89169. PMID 28138556 DOI: 10.1172/jci.insight.89169  0.68
2016 Lindenfeld J, Cleveland JC, Kao DP, White M, Wichman S, Bristow JC, Peterson V, Rodegheri-Brito J, Korst A, Blain-Nelson P, Sederberg J, Hunt SA, Gilbert EM, Ambardekar AV, Minobe W, ... ... Bristow MR, et al. Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptors. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 35: 352-61. PMID 26970472 DOI: 10.1016/j.healun.2015.10.021  0.48
2015 Kao DP, Lowes BD, Gilbert EM, Minobe W, Epperson LE, Meyer LK, Ferguson DA, Volkman AK, Zolty R, Borg CD, Quaife RA, Bristow MR. Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy. Circulation. Cardiovascular Genetics. 8: 270-83. PMID 25637602 DOI: 10.1161/CIRCGENETICS.114.000767  0.68
2013 Aleong RG, Sauer WH, Robertson AD, Liggett SB, Bristow MR. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure Circulation: Arrhythmia and Electrophysiology. 6: 137-143. PMID 23275278 DOI: 10.1161/CIRCEP.111.969618  0.48
2013 Kao DP, Davis G, Aleong R, O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Murphy GA, Sauer W, ... Bristow MR, et al. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. European Journal of Heart Failure. 15: 324-33. PMID 23223178 DOI: 10.1093/eurjhf/hfs181  0.48
2012 Kao DP, Wagner BD, Robertson AD, Bristow MR, Lowes BD. A Personalized BEST: Characterization of Latent Clinical Classes of Nonischemic Heart Failure That Predict Outcomes and Response to Bucindolol Plos One. 7. PMID 23144856 DOI: 10.1371/journal.pone.0048184  0.68
2012 O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Walsh R, Nelson P, Medway A, Davis G, Robertson AD, ... ... Bristow MR, et al. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms. Plos One. 7: e44324. PMID 23071495 DOI: 10.1371/journal.pone.0044324  0.48
2010 Bristow MR, Murphy GA, Krause-Steinrauf H, Anderson JL, Carlquist JF, Thaneemit-Chen S, Krishnan V, Abraham WT, Lowes BD, Port JD, Davis GW, Lazzeroni LC, Robertson AD, Lavori PW, Liggett SB. An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. Circulation. Heart Failure. 3: 21-8. PMID 19880803 DOI: 10.1161/CIRCHEARTFAILURE.109.885962  0.68
2009 Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, Lindenfeld J, O'Connor C, Steinberg JS, Leigh J, Yong P, Kosorok MR, Feldman AM, DeMets D, ... Bristow MR, et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation. 119: 969-77. PMID 19204305 DOI: 10.1161/CIRCULATIONAHA.108.793273  0.48
2007 Lowes BD, Zolty R, Shakar SF, Brieke A, Gray N, Reed M, Calalb M, Minobe W, Lindenfeld J, Wolfel EE, Geraci M, Bristow MR, Cleveland J. Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 26: 1170-6. PMID 18022084 DOI: 10.1016/j.healun.2007.08.003  0.68
2007 Tate CW, Robertson AD, Zolty R, Shakar SF, Lindenfeld J, Wolfel EE, Bristow MR, Lowes BD. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). Journal of Cardiac Failure. 13: 732-7. PMID 17996821 DOI: 10.1016/j.cardfail.2007.07.001  0.68
2007 Feldman AM, Oren RM, Abraham WT, Boehmer JP, Carson PE, Eichhorn E, Gilbert EM, Kao A, Leier CV, Lowes BD, Mathier MA, McGrew FA, Metra M, Zisman LS, Shakar SF, ... ... Bristow MR, et al. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. American Heart Journal. 154: 861-9. PMID 17967591 DOI: 10.1016/j.ahj.2007.06.044  0.68
2006 Quaife RA, Chen MY, Lynch D, Badesch DB, Groves BM, Wolfel E, Robertson AD, Bristow MR, Voelkel NF. Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress. European Journal of Medical Research. 11: 214-20. PMID 16723296  0.48
2006 Lowes BD, Zolty R, Minobe WA, Robertson AD, Leach S, Hunter L, Bristow MR. Serial Gene Expression Profiling in the Intact Human Heart Journal of Heart and Lung Transplantation. 25: 579-588. PMID 16678038 DOI: 10.1016/j.healun.2006.01.006  0.68
2005 Lowes BD, Shakar SF, Metra M, Feldman AM, Eichhorn E, Freytag JW, Gerber MJ, Liard JF, Hartman C, Gorczynski R, Evans G, Linseman JV, Stewart J, Robertson AD, Roecker EB, ... ... Bristow MR, et al. Rationale and design of the enoximone clinical trials program. Journal of Cardiac Failure. 11: 659-69. PMID 16360960 DOI: 10.1016/j.cardfail.2005.10.013  0.68
2005 Carson P, Anand I, O'Connor C, Jaski B, Steinberg J, Lwin A, Lindenfeld J, Ghali J, Ghali J, Barnet JH, Feldman AM, Bristow MR. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. Journal of the American College of Cardiology. 46: 2329-34. PMID 16360067 DOI: 10.1016/j.jacc.2005.09.016  0.48
2004 Bristow MR, Krause-Steinrauf H, Nuzzo R, Liang CS, Lindenfeld J, Lowes BD, Hattler B, Abraham WT, Olson L, Krueger S, Thaneemit-Chen S, Hare JM, Loeb HS, Domanski MJ, Eichhorn EJ, et al. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation. 110: 1437-42. PMID 15337700 DOI: 10.1161/01.CIR.0000141297.50027.A4  0.68
2004 Shakar SF, Lowes BD, Lindenfeld J, Zolty R, Simon M, Robertson AD, Bristow MR, Wolfel EE. Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers. Journal of Cardiac Failure. 10: 15-20. PMID 14966770  0.68
2003 Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. Journal of the American College of Cardiology. 42: 914-22. PMID 12957443  0.68
2003 Abraham WT, Raynolds MV, Badesch DB, Wynne KM, Groves BM, Roden RL, Robertson AD, Lowes BD, Zisman LS, Voelkel NF, Bristow MR, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: Increased frequency and association with preserved haemodynamics Jraas - Journal of the Renin-Angiotensin-Aldosterone System. 4: 27-30. PMID 12692750  0.68
2003 Linseman JV, Bristow MR. Drug therapy and heart failure prevention. Circulation. 107: 1234-6. PMID 12628939  0.68
2003 Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, ... ... Bristow MR, et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. Journal of the American College of Cardiology. 41: 771-80. PMID 12628721 DOI: 10.1016/S0735-1097(02)02954-6  0.68
2003 Bohlmeyer TJ, Helmke S, Ge S, Lynch J, Brodsky G, Sederberg JH, Robertson AD, Minobe W, Bristow MR, Perryman MB. Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 12: 23-31. PMID 12598014  0.48
2002 Abraham WT, Gilbert EM, Lowes BD, Minobe WA, Larrabee P, Roden RL, Dutcher D, Sederberg J, Lindenfeld JA, Wolfel EE, Shakar SF, Ferguson D, Volkman K, Linseman JV, Quaife RA, ... ... Bristow MR, et al. Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Molecular Medicine (Cambridge, Mass.). 8: 750-60. PMID 12520092  0.68
2002 Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol Journal of the American College of Cardiology. 40: 1248-1258. PMID 12383572 DOI: 10.1016/S0735-1097(02)02134-4  0.48
2002 Asano K, Bohlmeyer TJ, Westcott JY, Zisman L, Kinugawa K, Good M, Minobe WA, Roden R, Wolfel EE, Lindenfeld J, David Port J, Perryman MB, Clevel J, Lowes BD, Bristow MR. Altered expression of endothelin receptors in failing human left ventricles Journal of Molecular and Cellular Cardiology. 34: 833-846. PMID 12099722 DOI: 10.1006/jmcc.2002.2022  0.68
2002 Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. The New England Journal of Medicine. 346: 1357-65. PMID 11986409 DOI: 10.1056/NEJMoa012630  0.68
2001 Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. International Journal of Cardiology. 81: 141-9. PMID 11744130  0.68
2001 Lindenfeld J, Robertson AD, Lowes BD, Bristow MR. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers Journal of the American College of Cardiology. 38: 1950-1956. PMID 11738299 DOI: 10.1016/S0735-1097(01)01641-2  0.68
2001 Bristow MR, Shakar SF, Linseman JV, Lowes BD. Inotropes and beta-blockers: is there a need for new guidelines? Journal of Cardiac Failure. 7: 8-12. PMID 11605160  0.68
2001 Schleman KA, Lindenfeld JA, Lowes BD, Bristow MR, Ferguson D, Wolfel EE, Abraham WT, Zisman LS. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis. Journal of Cardiac Failure. 7: 4-12. PMID 11264544 DOI: 10.1054/jcaf.2001.22491  0.68
2000 Lowes BD, Higginbotham M, Petrovich L, DeWood MA, Greenberg MA, Rahko PS, Dec GW, LeJemtel TH, Roden RL, Schleman MM, Robertson AD, Gorczynski RJ, Bristow MR. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. Journal of the American College of Cardiology. 36: 501-8. PMID 10933364  0.68
2000 Noori A, Lindenfeld J, Wolfel E, Ferguson D, Bristow MR, Lowes BD. Beta-blockade in adriamycin-induced cardiomyopathy. Journal of Cardiac Failure. 6: 115-9. PMID 10908085  0.68
2000 Lowes BD, Simon MA, Tsvetkova TO, Bristow MR. Inotropes in the beta-blocker era. Clinical Cardiology. 23: III11-6. PMID 10754776  0.68
1999 Lindenfeld J, Lowes BD, Bristow MR. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. The Annals of Pharmacotherapy. 33: 1266-9. PMID 10630826  0.68
1999 Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure American Journal of Cardiology. 83: 1201-1205. PMID 10215284 DOI: 10.1016/S0002-9149(99)00059-4  0.68
1999 Quaife RA, Lynch D, Badesch DB, Voelkel NF, Lowes BD, Robertson AD, Bristow MR. Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy Journal of Cardiac Failure. 5: 46-54. PMID 10194660 DOI: 10.1016/S1071-9164(99)90024-6  0.68
1998 Bristow MR, Roden RL, Lowes BD, Gilbert EM, Eichhorn EJ. The role of third-generation beta-blocking agents in chronic heart failure. Clinical Cardiology. 21: I3-13. PMID 9853189  0.68
1998 Bristow MR, Zisman LS, Lowes BD, Abraham WT, Badesch DB, Groves BM, Voelkel NF, Lynch DMB, Quaife RA. The pressure-overloaded right ventricle in pulmonary hypertension Chest. 114: 101S-106S. PMID 9676654  0.68
1998 Shakar SF, Abraham WT, Gilbert EM, Robertson AD, Lowes BD, Zisman LS, Ferguson DA, Bristow MR. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure Journal of the American College of Cardiology. 31: 1336-1343. PMID 9581729 DOI: 10.1016/S0735-1097(98)00077-1  0.68
1998 Abraham WT, Lowes BD, Ferguson DA, Odom J, Kim JK, Robertson AD, Bristow MR, Schrier RW. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. Journal of Cardiac Failure. 4: 37-44. PMID 9573502 DOI: 10.1016/S1071-9164(98)90506-1  0.68
1997 Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AO, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR. Changes in gene expression in the intact human heart: Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium Journal of Clinical Investigation. 100: 2315-2324. PMID 9410910  0.68
1997 Bristow MR, Abraham WT, Yoshikawa T, White M, Hattler BG, Crisman TS, Lowes BD, Robertson AD, Larrabee P, Gilbert EM. Second- and third-generation beta-blocking drugs in chronic heart failure. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 11: 291-6. PMID 9211023  0.68
1995 Abraham WT, Raynolds MV, Gottschall B, Badesch DB, Wynne KM, Groves BM, Lowes BD, Bristow MR, Perryman MB, Voelkel NF. Importance of angiotensin-converting enzyme in pulmonary hypertension Cardiology (Switzerland). 86: 9-15. PMID 7614507 DOI: 10.1159/000176939  0.68
1994 Abraham WT, Lowes BD, White M, Ferguson DA, Scheffel CA, Wolfel EE, Lindenfeld J, Bristow MR. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure. Journal of Cardiac Failure. 1: 57-62. PMID 9420633  0.68
1994 Bristow MR, Lowes BD. Low-dose inotropic therapy for ambulatory heart failure. Coronary Artery Disease. 5: 112-8. PMID 7910094  0.68
1993 Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet (London, England). 342: 1073-5. PMID 8105309  0.68
Show low-probability matches.